Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset: A prospective cohort study of individuals with mild to critical COVID-19.
Wynberg E, Han AX, van Willigen HDG, Verveen A, van Pul L, Maurer I, van Leeuwen EM, van den Aardweg JG, de Jong MD, Nieuwkerk P, Prins M, Kootstra NA, de Bree GJ; RECoVERED Study Group. Wynberg E, et al. Among authors: van leeuwen em. PLoS One. 2024 Jul 15;19(7):e0304990. doi: 10.1371/journal.pone.0304990. eCollection 2024. PLoS One. 2024. PMID: 39008486 Free PMC article.
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.
Kamperman RG, van Leeuwen EM, Willems M, van der Kooi AJ, Gelderman KA, Hamann D, van Lochem EG, Meek B, van der Molen RG, Platteel AC, Otten HG, Schreurs MW; Dutch Myositis Network; Raaphorst J. Kamperman RG, et al. Among authors: van der molen rg, van der kooi aj, van leeuwen em, van lochem eg. J Autoimmun. 2023 Sep;139:103081. doi: 10.1016/j.jaut.2023.103081. Epub 2023 Jun 12. J Autoimmun. 2023. PMID: 37393780 No abstract available.
Cytotoxic human CD4(+) T cells.
van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. van de Berg PJ, et al. Among authors: van leeuwen em, van lier r. Curr Opin Immunol. 2008 Jun;20(3):339-43. doi: 10.1016/j.coi.2008.03.007. Epub 2008 Apr 24. Curr Opin Immunol. 2008. PMID: 18440213 Review.
T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Pothast CR, Hofsink Q, Haggenburg S, Dijkland RC, Van de Meent M, Van Dijk K, Bhoekhan MS, Haverkate NJE, Van Meerloo J, Falkenburg JHF, De Groen RAL, Broers AEC, Van Doesum JA, Van Binnendijk RS, Den Hartog G, Lissenberg-Witte BI, Kater AP, Smits GP, Wouters D, Van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Van Baarle D, De Vries RD, Van Meerten T, Mutsaers PGNJ, Goorhuis A, Nijhof IS, Hazenberg MD, Heemskerk MHM, Rutten CE; COBRA KAI study team. Pothast CR, et al. Among authors: van leeuwen emm. Haematologica. 2025 May 29. doi: 10.3324/haematol.2024.287136. Online ahead of print. Haematologica. 2025. PMID: 40438989 Free article.
140 results